Personal Chair (Clinical)
I have a programme of research in pre-invasive disease of the lower genital tract, clinical research trials and molecular studies in collaboration with Universities of Edinburgh, Dundee, Manchester, Nottingham and Strathclyde and NHS Scotland. The focus of this work relates to Human Papillomavirus infection (HPV) and cervical screening.
My main research interests include HPV related diseases, prevention of cervical cancer and the impact of HPV immunisation. In addition to colposcopy, my clinical areas of interest include vulva dermatosis and pain disorders.
The collaborators in our research programme have set up a Scottish HPV Investigators Research Network (SHINe) to promote collaboration and the development of HPV research. This includes the development of a national HPV archive funded by CSO BTR programme grant and collaboration to optimise our research strategy with the HPV surveillance work of Health Protection Scotland.
2011-2015: HTA (Grant holder). Strategies to Increase Cervical Screening Uptake at First Invitation (STRATEGIC). Universities of Aberdeen and Manchester
2010- 2016: CSO HSR Programme grant (Principal investigator) Long-term Follow-up of HPV vaccination in women attending first cervical smear: the impact of HPV immunisation on cervical screening and the prevention of HPV-related disease in Scottish women.
2009-2014: CSO BTR Programme grant (Grant holder) Long-term Follow-up of HPV vaccination in women attending first cervical smear – establishment and development of HPV research base.
Professor Maggie Cruickshank is responsible for the planning and co-ordination of Year 5 (Final Year) of the MB ChB course and participates in specialist teaching in Obstetrics and Gynaecology, including co-ordination of Year 3 Reproductive Health block.
- Further Info
Professor Maggie Cruickshank is Interim Director of NHS Grampian Research and Development
Page 1 of 8 Results 1 to 10 of 75
Contributions to Journals
- Kalampokas, E., Wilson, J., Gurumurthy, M. & Cruickshank, ME. (in press). 'The effect of high risk HPV but normal cytology at Test of cure on achieving colposcopy standards'. Journal of Lower Genital Tract Disease.
- Kavanagh, K., Pollock, KG., Cuschieri, K., Palmer, T., Cameron, RL., Watt, C., Bhatia, R., Moore, C., Cubie, H., Cruickshank, M. & Robertson, C. (2017). 'Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study'. Lancet Infectious Diseases, vol 17, no. 12, pp. 1293-1302.
[Online] DOI: 10.1016/S1473-3099(17)30468-1
- Munro, A., Gillespie, C., Cotton, S., Busby-Earle, C., Kavanagh, K., Cuschieri, K., Cubie, H., Robertson, C., Smart, L., Pollock, K., Moore, C., Palmer, T. & Cruickshank, ME. (2017). 'The impact of HPV type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two centre observational study'. BJOG-An International Journal of Obstetrics and Gynaecology, vol 124, no. 9, pp. 1394-1401.
[Online] DOI: 10.1111/1471-0528.14563
- Cruickshank, ME., Pan, J., Cotton, SC., Kavanagh, K., Robertson, C., Cuschieri, K., Cubie, H., Palmer, T. & Pollock, KG. (2017). 'Reduction in colposcopy workload and associated clinical activity following HPV catch-up vaccination programme in Scotland: an ecological study'. BJOG-An International Journal of Obstetrics and Gynaecology, vol 124, no. 9, pp. 1386-1393.
[Online] DOI: 10.1111/1471-0528.14562
- Fielding, S., Rothnie, K., Gray, NM., Little, J., Cruickshank, ME., Neal, K., Walker, LG., Whynes, D., Cotton, SC. & Sharp, L. (2017). 'Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial'. Psycho-Oncology, vol 26, no. 4, pp. 476–483.
[Online] DOI: 10.1002/pon.4163
[Online] AURA: SFielding_longitudinalPOSM_REVISION3_clean.docx
[Online] AURA: Supplemtal_Tables.docx
[Online] AURA: Figure_S1_CONSORT.docx
[Online] AURA: Figure1.tif
[Online] AURA: Figure_S2B.tif
[Online] AURA: Figure_S2A.tif
[Online] AURA: Fielding_et_al_2017_Psycho_Oncology.pdf
- Kyrgiou, M., Kalliala, IEJ., Mitra, A., Fotopoulou, C., Ghaem-Maghami, S., Martin-Hirsch, PPL., Cruickshank, M., Arbyn, M. & Paraskevaidis, E. (2017). 'Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test'. Cochrane Database of Systematic Reviews, no. 1, CD009836.
[Online] DOI: 10.1002/14651858.CD009836.pub2
[Online] AURA: Kyrgiou_et_al_2017_The_Cochrane_Library.pdf
- Leo, PJ., Madeleine, MM., Wang, S., Schwartz, SM., Newell, F., Kymmer, U., Hemminki, K., Hallmans, G., Tiews, S., Steinberg, W., Rader, JS., Castro, F., Safaeian, M., Franco, EL., Coutlee, F., Ohlsson, C., Cortes, A., Marshall, M., Mukhopadhyay, P., Cremin, K., Johnson, LG., Garland, S., Tabrizi, SN., Wentzensen, N., Sitas, F., Little, J., Cruickshank, M., Frazer, IH., Hildesheim, A. & Brown, MA. (2017). 'Defining the genetic susceptibility to cervical neoplasia - a genome-wide association study'. PLoS Genetics, vol 13, no. 8, 1006866.
[Online] DOI: 10.1371/journal.pgen.1006866
[Online] AURA: Defining_the_genetic_susceptibility_to_cervical_neoplasia_A_...
- VIVIANE Study Group (2016). 'Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study'. Lancet Infectious Diseases, vol 16, no. 10, pp. 1154-1168.
[Online] DOI: 10.1016/S1473-3099(16)30120-7
[Online] AURA: New_RV_Wheeler_et_al_The_Lancet_ID.docx
- Wheeler, CM., Skinner, SR., Rowena Del Rosario-Raymundo, M., Garland, SM., Chatterjee, A., Lazcano-Ponce, E., Salmeron, J., McNeil, S., Stapleton, JT., Bouchard, C., Martens, MG., Money, DM., Quek, SC., Romanowski, B., Vallejos, CS., ter Harmsel, B., Prilepskaya, V., Fong, KL., Kitchener, H., Minkina, G., Lim, YKT., Stoney, T., Chakhtoura, N., Cruickshank, ME., Savicheva, A., da Silva, DP., Ferguson, M., Molijn, AC., Quint, WGV., Hardt, K., Descamps, D., Suryakiran, PV., Karkada, N., Geeraerts, B., Dubin, G., Struyf, F. & VIVIANE Study Grp (2016). 'Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study'. Lancet Infectious Diseases, vol 16, no. 10, pp. 1154-1168.
[Online] DOI: 10.1016/S1473-3099(16)30120-7
- Kitchener, HC., Gittins, M., Rivero-Arias, O., Tsiachristas, A., Cruickshank, M., Gray, A., Brabin, L., Torgerson, D., Crosbie, EJ., Sargent, A. & Roberts, C. (2016). 'A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)'. Health Technology Assessment, vol 20, no. 68, pp. 1-138.
[Online] DOI: 10.3310/hta20680
[Online] AURA: FullReport_hta20680.pdf